Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series. (24th August 2022)

• Record Type: Journal Article
• Authors: Doub, James B; Johnson, Aaron J; Nandi, Sumon; Ng, Vincent; Manson, Theodore; Lee, Myounghee; Chan, Benjamin
• Is Part Of: Clinical infectious diseases. Volume 76:Number 3(2023)
• Page Start: e1463
• Page End: e1466
• Publication Date: 2022-08-24
• Subjects: bacteriophage therapy -- periprosthetic joint infections -- Staphylococcus -- intraarticular -- debridement and implant retention surgery; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciac694
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Periprosthetic joint infections are a devastating complication of joint replacement surgery. One novel therapeutic that has potential to change the current treatment paradigm is bacteriophage therapy. Herein, we discuss our experiences with bacteriophage therapy for 10 recalcitrant periprosthetic joint infections and review the treatment protocols utilized to achieve successful outcomes.